Metagenomi Therapeutics (MGX) Shares Issued (2023 - 2026)
Metagenomi Therapeutics (MGX) posted quarterly Shares Issued of $1.3 million for Q1 2026, up 426.58% year-over-year from $238515.0 in Q1 2025, and up 4.84% quarter-over-quarter from $1.2 million in Q4 2025.
Metagenomi Therapeutics (MGX) Shares Issued (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has reported Shares Issued for 4 consecutive years, with $1.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Shares Issued rose 426.58% year-over-year to $1.3 million; the TTM figure through Mar 2026 stood at $1.3 million (up 426.58% YoY), while the FY2025 annual figure was $1.2 million, up 637.91% from the prior year.
- Shares Issued grew to $1.3 million in Q1 2026 per MGX's latest filing, from $1.2 million in the prior quarter.
- Across five years, Shares Issued topped out at $9.5 million in Q4 2023 and bottomed at $3246.0 in Q2 2024.
- Historically, Shares Issued has averaged $1.6 million across 4 years, with a median of $890553.0 in 2025.
- Annual changes were most pronounced in 2024 — Shares Issued sank 98.29% — and 2025, when it surged 27335.4%.
- Metagenomi Therapeutics' Shares Issued stood at $9.5 million in 2023, then tumbled by 98.29% to $162349.0 in 2024, then jumped by 637.91% to $1.2 million in 2025, then climbed by 4.84% to $1.3 million in 2026.
- Business Quant data shows MGX's Shares Issued at $1.3 million in Q1 2026, $1.2 million in Q4 2025, and $1.1 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Metagenomi Therapeutics | 46.51 Mn | 46.51 Mn | - | 13,852.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.64 Mn |
| Jun 30, 2026 | 1.64 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Mar 31, 2026 | 1.26 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Sep 30, 2025 | 1.06 Mn |
| Jun 30, 2025 | 890,553.00 |
| Jun 30, 2025 | 890,553.00 |
| Mar 31, 2025 | 238,515.00 |
| Mar 31, 2025 | 238,515.00 |
| Dec 31, 2024 | 162,349.00 |
| Dec 31, 2024 | 162,349.00 |
| Sep 30, 2024 | 118,954.00 |
| Sep 30, 2024 | 118,954.00 |
| Jun 30, 2024 | 3,246.00 |
| Jun 30, 2024 | 3,246.00 |
| Dec 31, 2023 | 9.49 Mn |
| Dec 31, 2023 | 9.49 Mn |